Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 2/20 | 0.71 |
| ▸ | CA12 | O43570 | 1/20 | 0.71 |
| ▸ | CA9 | Q16790 | 1/20 | 0.71 |
| ▸ | POLB | P06746 | 1/20 | 0.66 |
| ▸ | PGR | P06401 | 1/20 | 0.65 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.63 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.63 |
| ▸ | CASP3 | P42574 | 1/20 | 0.62 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.62 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.62 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.62 |
| ▸ | MEN1 | O00255 | 3/20 | 0.61 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.61 |
| ▸ | LMNA | P02545 | 1/20 | 0.61 |
| ▸ | MAPT | P10636 | 1/20 | 0.61 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.61 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.61 |
| ▸ | CRHBP | P24387 | 1/20 | 0.59 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.59 |
| ▸ | PKM | P14618 | 1/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4101284 | 0.91 | PGR (0.78) | CA2CA12CA9PGRALDH1A1 | |
| SCHEMBL1471804 | 0.89 | PGR (0.79) | CA2CA12CA9POLBPGR | |
| SCHEMBL27888184 | 0.88 | HTR6 (0.68) | CA2CA12CA9POLBPGR | |
| SCHEMBL27927882 | 0.88 | POLB (0.63) | CA2CA12CA9POLBALDH1A1 | |
| SCHEMBL7336569 | 0.87 | CA2 (0.71) | CA2CA12CA9POLBPGR | |
| SCHEMBL1472101 | 0.87 | MEN1 (0.72) | CA2CA12CA9POLBPGR | |
| SCHEMBL12111855 | 0.86 | CA12 (0.70) | CA2CA12CA9POLBPGR | |
| SCHEMBL16431026 | 0.85 | PGR (0.64) | CA2POLBPGRALDH1A1CASP3 | |
| SCHEMBL2242888 | 0.83 | CA2 (1.00) | CA2CA12CA9ALDH1A1MEN1 | |
| SCHEMBL15043011 | 0.82 | ALDH1A1 (0.66) | CA2PGRALDH1A1CASP3SENP8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 50 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12427798-B2 | Heat-sensitive recording composition | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2025-09-30 | — | — | US | disclosed |
| US-20250001788-A1 | HEAT-SENSITIVE RECORDING COMPOSITION | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2025-01-02 | — | — | US | disclosed |
| EP-4442467-A1 | THERMAL RECORDING COMPOSITION | Nippon Kayaku Kabushiki Kaisha (JP) | 2024-10-09 | — | — | EP | disclosed |
| EP-4442468-A1 | HEAT-SENSITIVE RECORDING COMPOSITION | Nippon Kayaku Kabushiki Kaisha (JP) | 2024-10-09 | — | — | EP | disclosed |
| US-20240326501-A1 | HEAT-SENSITIVE RECORDING COMPOSITION | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2024-10-03 | — | — | US | disclosed |
| CN-112533967-B | Oil-in-water droplet type emulsion of active energy ray-curable resin composition and thermosensitive recording material | 日本化药株式会社 | 2023-09-15 | — | — | CN | disclosed |
| WO-2023100900-A1 | THERMAL RECORDING COMPOSITION | 日本化薬株式会社 | 2023-06-08 | — | — | WO | disclosed |
| WO-2023100902-A1 | HEAT-SENSITIVE RECORDING COMPOSITION | 日本化薬株式会社 | 2023-06-08 | — | — | WO | disclosed |
| US-11643396-B2 | BRD4-kinase inhibitors as cancer therapeutics | H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC. (US) | 2023-05-09 | — | — | US | disclosed |
| US-11612604-B2 | Methods of treating cancer with PLK4 inhibitors | LUDWIG INSTITUTE FOR CANCER RESEARCH LTD (CH) | 2023-03-28 | — | — | US | disclosed |
| US-6133315-A | ADMINISTERING TO TREAT PANCREATITIS, THROMBOSIS, ISCHEMIA, STROKE, RESTENOSIS, EMPHYSEMA OR INFLAMMATION IN A MAMMAL; COMPOUNDS SUCH AS 2-CHLOROBENZENESULFONIC ACID 3-(3-AMIDINOPROPOXY)-5-METHYLPHENYL ESTER HYDROCHLORIDE | 3-DIMENSIONAL PHARMACEUTICALS, INC. (US) | 2000-10-17 | — | — | US | disclosed |
| US-6034127-A | CARDIOVASCULAR DISORDERS; RESPIRATORY SYSTEM DISORDERS | 3-DIMENSIONAL PHARMACEUTICALS, INC. (US) | 2000-03-07 | — | — | US | disclosed |
| EP-0859607-A4 | GUANIDINO PROTEASE INHIBITORS | DIMENSIONAL PHARM INC (US) | 1999-05-06 | — | — | EP | disclosed |
| EP-0883405-A4 | AMIDINO PROTEASE INHIBITORS | DIMENSIONAL PHARM INC (US) | 1999-04-28 | — | — | EP | disclosed |
| EP-0883405-A1 | AMIDINO PROTEASE INHIBITORS | 3-DIMENSIONAL PHARMACEUTICALS, INC. (US) | 1998-12-16 | — | — | EP | disclosed |
| EP-0859607-A1 | GUANIDINO PROTEASE INHIBITORS | 3-DIMENSIONAL PHARMACEUTICALS, INC. (US) | 1998-08-26 | — | — | EP | disclosed |
| US-5792769-A | POTENT ANTICOAGULANT, ANTIINFLAMMATORY AGENT; TREATMENT/PROPHYLAXIS OF RESPIRATORY SYSTEM DISORDERS, VASCULAR SYSTEM DISORDERS, ANTITUMOR AGENTS | 3-DIMENSIONAL PHARMACEUTICALS, INC. (US) | 1998-08-11 | — | — | US | disclosed |
| WO-1997024135-A1 | AMIDINO PROTEASE INHIBITORS | 3-DIMENSIONAL PHARMACEUTICALS, INC. (US) | 1997-07-10 | — | — | WO | disclosed |
| WO-1997011693-A1 | GUANIDINO PROTEASE INHIBITORS | 3-DIMENSIONAL PHARMACEUTICALS, INC. (US) | 1997-04-03 | — | — | WO | disclosed |
| US-4025614-A | Substituted 2H-pyran-2,6 (3H)-dione derivatives useful in treatment of allergic reactions | SMITHKLINE CORPORATION (US) | 1977-05-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11612604-B2 | Methods of treating cancer with PLK4 inhibitors | PLK4, PLK2, PLK3 | CA2 3588/4885CA12 4369/4885CA9 3385/4885 |
| US-11643396-B2 | BRD4-kinase inhibitors as cancer therapeutics | BRD4, BICRA, BRDT | CA2 4824/4885CA12 4724/4885CA9 4585/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.